-+ 0.00%
-+ 0.00%
-+ 0.00%

UiPath (PATH) Stock May Be 40% Undervalued On Fresh AI Contract News

Simply Wall St·07/16/2026 23:37:01
语音播报

UiPath stock is coming off a difficult five year stretch, with the share price well below where early investors bought in. Yet current valuation checks suggest the market price may still sit at a discount to what the company’s cash flows could justify. That creates a clear tension for investors weighing whether the recent weakness has already priced in the main concerns or whether caution is still warranted.

  • Over the past five years, UiPath shareholders have seen the stock decline 80.7%, which means any case for value today has to be weighed against a long period of disappointment.
  • Recent interest in UiPath’s role in AI driven automation, including a new contract with The Very Group, can support optimism on future revenue. At the same time, questions around execution quality and customer retention remain a risk for how much of that expectation turns into durable cash flow.
  • On Simply Wall St’s broader checks, UiPath screens as undervalued in 5 of 6 key valuation tests. This points to a stock that currently leans cheap rather than expensive.

The issue now is whether UiPath’s current share price already reflects the operational risks or still offers a valuation gap that could close over time.

UiPath delivered -2.4% returns over the last year. See how this stacks up to the rest of the Software industry.

Is UiPath Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what UiPath could be worth based on the cash it is expected to generate for shareholders. For UiPath, the model starts with latest twelve month free cash flow of about $368.4 million and applies a growing cash flow profile rather than assuming a mature, flat business. This fits a company still building out its automation and AI platform.

On this basis, the 2 Stage Free Cash Flow to Equity model points to an estimated intrinsic value of about $20.11 per share. With the stock recently around $11.80, the DCF implies UiPath is about 40.2% undervalued. The recent Very Group AI contract, while still unproven in terms of long term impact, helps explain why the cash flow outlook embedded in this model remains more optimistic than what the current share price reflects.

Overall, the DCF work suggests UiPath stock currently screens as undervalued relative to its forecast cash generation.

Our Discounted Cash Flow (DCF) analysis suggests UiPath is undervalued by 40.2%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

PATH Discounted Cash Flow as at Jul 2026
PATH Discounted Cash Flow as at Jul 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for UiPath.

Is UiPath a Bargain on Earnings?

For a company like UiPath that is now reporting GAAP profits, the P/E multiple gives a straightforward snapshot of how the market is pricing those earnings. UiPath trades on a P/E of about 19.0x, which sits well below the broader software industry average of 28.8x and also below the peer group average of 40.8x.

The more tailored fair P/E for UiPath, which factors in its growth profile, margins, size and risk, sits at roughly 24.8x. That is still above the current 19.0x level, indicating the stock trades at a discount after adjusting for company specific risks rather than just comparing to raw industry averages. In other words, the market is currently pricing UiPath at a lower multiple than both its sector and what this fair value framework suggests.

Taken together, UiPath appears undervalued on its P/E multiple relative to both industry peers and its own fair P/E benchmark.

NYSE:PATH P/E Ratio as at Jul 2026
NYSE:PATH P/E Ratio as at Jul 2026

See what the numbers say about this price — find out in our valuation breakdown.

The UiPath Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the UiPath valuation puzzle leaves off by spelling out what would need to be true about UiPath's future growth, margins and earnings for the stock to be worth materially more or materially less than today's price. Each narrative presents a fair value as a thesis about the business that you can revisit over time, and these sit on Simply Wall St's Community page for you to explore in more detail.

Community views on UiPath sit on very different sides of the fence, with one camp focused on agentic AI upside and the other on execution risk around turning interest into durable ARR.

Bull case: 10% undervalued

"UiPath's focus on accelerating innovation across the agentic automation road map is expected to grow deeper customer relationships and strategic partnerships, likely driving future revenue growth…"

Read the full Bull Case to see why UiPath could be undervalued

Bear case: 10% overvalued

"Although customer interest in agentic automation is helping AI product ARR reach nearly US$200 million, the company still depends on turning proof of concepts into scaled deployments, so the impact on total revenue and dollar-based net retention will hinge on how quickly these projects move beyond testing stages…"

Read the full Bear Case to see why UiPath could be overvalued

Do you think there's more to the story for UiPath? Head over to our Community to see what others are saying!

The Bottom Line

For UiPath, both the Discounted Cash Flow (DCF) intrinsic value estimate and the P/E based view currently point in the same direction, with the stock screening as undervalued on cash flows and earnings multiples. The broader valuation checks are also supportive, so the key question is not whether UiPath looks cheap today, but whether it can convert interest in AI driven automation into stable customer adoption and cash generation. The crux from here is whether execution and retention improve enough for that apparent discount to close, or whether the current gap simply reflects the ongoing risk that strong interest does not consistently translate into durable revenue and cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.